Vectura Limited
1 Prospect West
Chippenham
SN14 6FH
United Kingdom
Tel: 44-0-1249-667700
Fax: 44-0-1249-667701
Website: http://www.vectura.com
Email: enquiries@vectura.com
8 articles about Vectura Limited
-
Mundipharma AG Signs New Deal With Vectura Limited For Global Development And Commercialization Of Inhaled Triple Therapy VR2076 For The Treatment Of Asthma And COPD
12/27/2016
-
Vectura Limited Pays A Whopping $181 Million For Activaero
3/13/2014
-
Vectura Limited Gets $7.5 Million as Novartis Corporation Starts Key Trial
5/10/2010
-
Vectura Limited and Sandoz Pharmaceuticals Revise VR315 Agreement; Vectura to Receive $9.5 Million Payment and up to $25 Million Loan Facility
3/18/2010
-
GlaxoSmithKline Up as Novartis Corporation Drops Generic Advair in U.S.; Novartis Hands Back U.S. Rights to VR315 to Vectura Limited
3/18/2010
-
Vectura Limited Revenue Up, Key Drugs to Start Phase III
5/19/2009
-
Vectura, Evolutec File To Try IPO Luck On London Market
6/16/2004
-
Vectura Inhaler For Male Erectile Dysfunction
6/16/2004